Christopher Tovey
Chief Executive Officer bei DESTINY PHARMA PLC
Profil
Derzeit ist Christopher John Tovey Chief Operating Officer bei GW Pharmaceuticals Plc. Er ist außerdem Mitglied des Vorstands von CanImGuide Therapeutics AB, GW Research Ltd. und GW Pharma Ltd. Herr Tovey hatte zuvor die Position des Director-Vaccines Business Unit bei GlaxoSmithKline Plc und des Vice President-Global Marketing Operations bei UCB SA inne. Er erhielt einen Bachelor-Abschluss von der University of Liverpool.
Aktive Positionen von Christopher Tovey
| Unternehmen | Position | Beginn |
|---|---|---|
| DESTINY PHARMA PLC | Chief Executive Officer | 01.09.2023 |
GW Research Ltd.
 GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a private company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995. | Director/Board Member | 01.10.2012 |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Board Member | - |
GW Pharma Ltd.
 GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999. | Director/Board Member | 01.10.2012 |
Ehemalige bekannte Positionen von Christopher Tovey
| Unternehmen | Position | Ende |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Chief Operating Officer | 01.10.2022 |
| GW PHARMACEUTICALS PLC | Chief Operating Officer | - |
| UCB | Corporate Officer/Principal | 01.09.2012 |
| GSK PLC | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Christopher Tovey
| The University of Liverpool | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| GSK PLC | Health Technology |
| UCB | Health Technology |
| DESTINY PHARMA PLC | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
GW Research Ltd.
GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a private company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995. | Commercial Services |
GW Pharma Ltd.
GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999. | Health Technology |
